Ind-Swift Limited
NSE: INDSWFTLTD BSE: INDSWFTLTD
NSE
15.76
0.91 (6.13%)
Prev Close
14.85
Open Price
15.16
Volume
630,284
Today Low / High
15.15 / 17.82
52 WK Low / High
12 / 34.7
Range
15 - 17
BSE
15.70
0.72 (4.81%)
Prev Close
14.98
Open Price
14.86
Volume
97,760
Today Low / High
14.86 / 17.82
52 WK Low / High
12 / 34.49
Range
15 - 16
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 15.76 (target range: 15 - 17), reflecting a change of 0.91 (6.12795%). On the BSE, it is listed at 15.7 (target range: 15 - 16), showing a change of 0.72 (4.80641%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
08 Aug
15.75
-1.78%
07 Aug
16.15
-4.09%
06 Aug
16.56
-3.62%
05 Aug
16.60
-1.45%
04 Aug
16.35
0.61%
01 Aug
16.70
-0.30%
31 Jul
16.50
1.27%
30 Jul
16.74
-0.48%
29 Jul
16.41
1.52%
28 Jul
16.64
-1.38%
25 Jul
16.80
-0.95%
24 Jul
17.36
-2.94%
23 Jul
18.50
-6.16%
22 Jul
17.64
1.70%
21 Jul
17.44
1.15%
Ind-Swift Limited Graph
Ind-Swift Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ind-Swift Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 15.76, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 15.70 | 15.86 | 14.27 - 17.44 |
| 16.01 | 12.81 - 19.22 | ||
| 16.17 | 11.32 - 21.02 | ||
| Bearish Scenario | 15.70 | 15.54 | 13.99 - 17.10 |
| 15.39 | 12.31 - 18.46 | ||
| 15.23 | 10.66 - 19.80 |
Overview of Ind-Swift Limited
ISIN
INE788B01028
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
177,673
Market Cap
837,927,909
Last Dividend
0
Official Website
IPO Date
2004-10-18
DCF Diff
32.60
DCF
-14
Financial Ratios Every Investor Needs
Stock Dividend of INDSWFTLTD
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2011-09-21 | September 21, 11 | 0.4 | 0.4 | 2011-09-22 | 2011-10-26 | 2011-09-02 |
| 2010-09-24 | September 24, 10 | 0.4 | 0.4 | 2010-09-27 | 2010-10-30 | 2010-09-07 |
| 2009-09-17 | September 17, 09 | 0.4 | 0.4 | 2009-09-19 | 2009-10-24 | 2009-08-21 |
| 2008-09-19 | September 19, 08 | 0.4 | 0.4 | 2008-09-23 | 2008-11-01 | 2008-08-25 |
| 2007-09-21 | September 21, 07 | 0.4 | 0.4 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 515.23 Cr | 260.18 Cr | 255.05 Cr | 0.4950 | 0.00 Cr | 0.00 Cr | -0.52 Cr | 283.45 Cr | 52.33 | 350.57 Cr | 0.5501 |
| 2024-03-31 | 502.47 Cr | 285.22 Cr | 217.25 Cr | 0.4324 | 9.79 Cr | 78.61 Cr | 32.17 Cr | 14.23 Cr | 2.63 | 106.51 Cr | 0.0283 |
| 2023-03-31 | 398.89 Cr | 241.89 Cr | 157.00 Cr | 0.3936 | 9.59 Cr | 16.97 Cr | 16.19 Cr | 26.04 Cr | 4.81 | 114.47 Cr | 0.0653 |
| 2022-03-31 | 391.30 Cr | 236.11 Cr | 155.19 Cr | 0.3966 | 5.24 Cr | 12.29 Cr | 31.06 Cr | -20.02 Cr | -3.70 | 69.63 Cr | -0.0512 |
| 2021-03-31 | 352.16 Cr | 209.77 Cr | 142.40 Cr | 0.4043 | 3.90 Cr | 10.34 Cr | 18.03 Cr | -29.82 Cr | -5.50 | 55.39 Cr | -0.0847 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 69.51 Cr | 727.95 Cr | 1,130.28 Cr | -402.3280 Cr | 873.75 Cr | 804.24 Cr | 107.25 Cr | 231.99 Cr | 0.00 Cr | 0.00 Cr | 80.76 Cr | 280.9118 Cr |
| 2024-03-31 | 63.14 Cr | 654.47 Cr | 1,345.30 Cr | -690.8252 Cr | 1,014.00 Cr | 950.86 Cr | 64.09 Cr | 224.77 Cr | 0.00 Cr | 0.00 Cr | 1.26 Cr | 320.3669 Cr |
| 2023-03-31 | 13.33 Cr | 649.21 Cr | 1,353.91 Cr | -704.6988 Cr | 992.62 Cr | 979.29 Cr | 89.35 Cr | 234.27 Cr | 51.77 Cr | 0.00 Cr | 1.26 Cr | 936.3304 Cr |
| 2022-03-31 | 16.18 Cr | 631.76 Cr | 1,352.08 Cr | -720.3211 Cr | 1,021.67 Cr | 1,018.81 Cr | 69.58 Cr | 234.12 Cr | 35.02 Cr | 0.00 Cr | 1.28 Cr | 717.5901 Cr |
| 2021-03-31 | 28.99 Cr | 671.57 Cr | 1,366.74 Cr | -695.1644 Cr | 1,008.54 Cr | 985.50 Cr | 62.85 Cr | 245.14 Cr | 13.41 Cr | 0.00 Cr | 1.86 Cr | 706.1600 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 15.8560 Cr | 3.2279 Cr | -12.7105 Cr | -24.8652 Cr | 6.3734 Cr | 69.5102 Cr | -40.7212 Cr | 7.9418 Cr | 25.8633 Cr | 0.0000 Cr | -43.1578 Cr |
| 2024-03-31 | 15.2828 Cr | 76.6072 Cr | -42.0810 Cr | -13.2103 Cr | 49.8090 Cr | 63.1368 Cr | -28.4931 Cr | 14.2313 Cr | 21.3798 Cr | 0.0000 Cr | 25.2567 Cr |
| 2023-03-31 | 73.0459 Cr | -29.3450 Cr | -46.5556 Cr | 42.2161 Cr | -2.8547 Cr | 13.3278 Cr | -30.8298 Cr | -34.5420 Cr | 17.5392 Cr | 0.0000 Cr | -19.7655 Cr |
| 2022-03-31 | 50.2021 Cr | -18.4163 Cr | -44.5950 Cr | 30.6257 Cr | -12.8092 Cr | 16.1825 Cr | -19.5764 Cr | -20.3364 Cr | -24.1380 Cr | 0.0000 Cr | -6.7366 Cr |
| 2021-03-31 | 83.1928 Cr | -16.7126 Cr | -54.2471 Cr | 62.9770 Cr | 12.2331 Cr | 28.9917 Cr | -20.2158 Cr | -29.8160 Cr | -0.0467 Cr | 0.0000 Cr | -10.4409 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 144.90 Cr | 71.14 Cr | 73.77 Cr | 0.5091 | -9.15 Cr | 256.60 Cr | 47.37 | 278.40 Cr | 1.7708 |
| 2024-12-31 | 120.13 Cr | 55.45 Cr | 64.68 Cr | 0.5384 | 1.77 Cr | -5.50 Cr | -1.02 | 9.98 Cr | -0.0458 |
| 2024-09-30 | 136.35 Cr | 69.89 Cr | 66.46 Cr | 0.4874 | 9.01 Cr | 4.11 Cr | 0.76 | 19.03 Cr | 0.0302 |
| 2024-06-30 | 113.85 Cr | 63.71 Cr | 50.15 Cr | 0.4404 | 30.21 Cr | 28.24 Cr | 5.21 | 43.15 Cr | 0.2480 |
| 2024-03-31 | 135.23 Cr | 99.32 Cr | 35.91 Cr | 0.2656 | 7.61 Cr | 37.54 Cr | 6.93 | 61.08 Cr | 0.2776 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 69.51 Cr | 11.31 Cr | 80.82 Cr | 158.68 Cr | 107.25 Cr | 399.83 Cr | 231.99 Cr | 727.95 Cr | 1,130.28 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 68.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 658.47 Cr |
| 2024-09-30 | 68.85 Cr | 0.00 Cr | 68.85 Cr | 161.62 Cr | 88.46 Cr | 383.81 Cr | 212.43 Cr | 685.57 Cr | 1,344.04 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 63.14 Cr | 0.00 Cr | 0.00 Cr | 63.14 Cr | 0.00 Cr | 0.00 Cr | 690.83 Cr |
| 2024-03-31 | 63.14 Cr | 0.00 Cr | 63.14 Cr | 152.14 Cr | 64.09 Cr | 341.79 Cr | 224.77 Cr | 654.47 Cr | 1,345.30 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -5.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 4.11 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 28.24 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 37.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -14.97 Cr | 13.55 Cr | 0.00 Cr | 0.00 Cr | 13.55 Cr | 28.51 Cr | 14.95 Cr | 0.00 Cr | 13.55 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2005-04-29 | April 29, 05 | 5:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,640.90 | ₹3,936,978,552,000.00 | ₹1,313,620.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,100.50 | ₹1,619,493,634,500.00 | ₹394,932.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,617.80 | ₹1,224,426,321,000.00 | ₹287,405.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,253.40 | ₹1,043,245,022,805.00 | ₹1,191,889.00 |
| Mankind Pharma Limited | MANKIND | ₹2,466.00 | ₹1,017,789,122,160.00 | ₹376,033.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.60 | ₹994,758,978,000.00 | ₹1,911,246.00 |
| Lupin Limited | LUPIN | ₹1,989.80 | ₹908,835,180,600.00 | ₹875,748.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,388.50 | ₹644,276,002,500.00 | ₹899,623.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,078.20 | ₹626,220,716,400.00 | ₹444,368.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,029.30 | ₹572,670,489,300.00 | ₹466,363.00 |
| Laurus Labs Limited | LAURUSLABS | ₹863.15 | ₹465,949,948,750.00 | ₹2,817,579.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹986.05 | ₹377,230,198,238.00 | ₹177,879.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,364.60 | ₹346,204,478,400.00 | ₹113,365.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,671.70 | ₹333,791,511,200.00 | ₹40,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,715.50 | ₹268,163,529,000.00 | ₹62,276.00 |
| Piramal Enterprises Limited | PEL | ₹1,127.20 | ₹255,511,441,600.00 | ₹243,681.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,501.60 | ₹243,978,466,400.00 | ₹325,967.00 |
| Eris Lifesciences Limited | ERIS | ₹1,674.80 | ₹228,119,483,600.00 | ₹42,022.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,416.50 | ₹210,412,500,000.00 | ₹34,705.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹941.00 | ₹184,965,783,000.00 | ₹25,900.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,077.50 | ₹171,625,277,500.00 | ₹132,577.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,018.00 | ₹167,019,638,200.00 | ₹23,483.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,156.90 | ₹163,949,635,730.00 | ₹164,102.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹904.25 | ₹161,960,217,500.00 | ₹516,819.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹460.35 | ₹111,701,165,400.00 | ₹778,530.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,182.50 | ₹102,625,790,500.00 | ₹13,202.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹906.20 | ₹88,618,113,580.00 | ₹114,891.00 |
| Strides Pharma Science Limited | STAR | ₹867.30 | ₹79,941,382,710.00 | ₹568,013.00 |
| FDC Limited | FDC | ₹483.20 | ₹78,669,792,000.00 | ₹76,497.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹790.45 | ₹71,642,135,379.00 | ₹1,229,147.00 |
| Innova Captab Limited | INNOVACAP | ₹902.00 | ₹51,616,886,860.00 | ₹24,559.00 |
| Suven Life Sciences Limited | SUVEN | ₹232.25 | ₹50,647,686,500.00 | ₹235,893.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.28 | ₹46,172,990,160.00 | ₹192,243.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹488.05 | ₹44,544,323,500.00 | ₹79,719.00 |
| Sequent Scientific Limited | SEQUENT | ₹171.51 | ₹42,934,955,850.00 | ₹221,470.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹768.10 | ₹38,957,340,710.00 | ₹102,241.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,281.60 | ₹37,735,382,400.00 | ₹9,674.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹513.80 | ₹36,174,500,040.00 | ₹45,592.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹356.70 | ₹35,769,162,600.00 | ₹36,115.00 |
| Hikal Limited | HIKAL | ₹255.65 | ₹31,521,900,650.00 | ₹589,191.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹605.30 | ₹29,147,010,900.00 | ₹54,573.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹93.23 | ₹27,365,522,210.00 | ₹1,598,864.00 |
| Indoco Remedies Limited | INDOCO | ₹293.70 | ₹27,093,208,230.00 | ₹138,144.00 |
| Alembic Limited | ALEMBICLTD | ₹105.19 | ₹27,010,898,475.00 | ₹451,825.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹47.31 | ₹25,923,703,740.00 | ₹3,167,804.00 |
Key Executives
Joint MD & Whole Time Director
Dr. Vikrant Rai Mehta M.Sc
Gender: Not Specified
Year Born: 1958
Associate Vice President of Marketing
Mr. Rajinder Kumar Gupta
Gender: male
Year Born:
Executive Chairman
Mr. Sanjeev Rai Mehta BSc
Gender: male
Year Born: 1956
Chief Operating Officer
Mr. Anil Agrawal
Gender: male
Year Born:
Vice President of Human Resources
Mr. Om Prakash Thapliyal
Gender: male
Year Born:
Associate Vice President of Quality
Ms. Suchitra Bhatnagar
Gender: female
Year Born:
Chief Executive Officer, MD & Whole Time Director
Dr. Gopal Munjal M.D.
Gender: Not Specified
Year Born: 1958
Company Secretary & Compliance Officer
Mr. Puneet Khurana
Gender: male
Year Born:
Chief Financial Officer & GM of Finance & Accounts
Mr. Arun K. Seth
Gender: male
Year Born:
Head of Administration
Ms. Annie Mehta
Gender: female
Year Born:
FAQs about Ind-Swift Limited
Who is the CEO of the company?
The CEO is Gopal Munjal.
What is the current market price of the stock?
The current price is ₹15.47.
What is the 52-week price range?
The range is ₹12-34.7.
What is the market capitalization of the company?
The market capitalization is ₹83.79 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 0.30.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ind-Swift Limited (ISIN: INE788B01028) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹83.79 crores and an average daily volume of 177,673 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.